Cardiology News and Research

Latest Cardiology News and Research

Treating critically ill COVID-19 patients with steroid improves chances of recovery

A new international study published today [02 September] has shown that treating critically ill patients with COVID-19 with the steroid hydrocortisone improves their chances of recovery.

2 Sep 2020

Rheumatoid arthritis drugs help improve the early stages of heart disease

Drugs used to treat initial signs of rheumatoid arthritis also improve the early stages of heart disease, according to new research.

2 Sep 2020

New emergency program provides mental health care across Colorado

The COVID-19 pandemic's effects run deep - far beyond the virus's immediate infections. From loss of livelihoods to drastic decreases in social connection, people across the country are suffering ongoing emotional strain.

2 Sep 2020

Circadian rhythms help in brain's unique process of waste removal

New research details how the complex set of molecular and fluid dynamics that comprise the glymphatic system - the brain's unique process of waste removal - are synchronized with the master internal clock that regulates the sleep-wake cycle.

2 Sep 2020

New theory changes the understanding of complex social interactions

Tracking the extent to which other people think differently from yourself appears to be more relevant than understanding someone else's thoughts per se. Neuroscientists at Ghent University and the University of New South Wales (Sydney) came to this conclusion.

2 Sep 2020

Exponential rise in COVID-19 hospitalization risk with age due to waning T cell immunity

The age-related increase in the risk of severe disease and death from COVID-19 mirrors earlier patterns seen with infections. Such trends may help understand the mechanisms underlying the clinical feature. A recent study published in the preprint server medRxiv* in August 2020 shows the effect of age and sex on COVID-19 hospitalization rates in the USA and helps understand how immune function is involved in this pandemic.

2 Sep 2020

Simple test can help healthcare professionals identify patients at risk of type 2 diabetes

A simple test such as the strength of your handgrip could be used as a quick, low-cost screening tool to help healthcare professionals identify patients at risk of type 2 diabetes.

2 Sep 2020

Misfiring brain cells may create swallowing difficulties in children with neurodevelopmental disorders

Misfiring brain cells that control key parts of the mouth and tongue may be creating swallowing difficulties in children with neurodevelopmental disorders, according to neuroscientists with Virginia Tech and George Washington University.

2 Sep 2020

Negligible ACE2 expression in human beta-cells

Now, a new study published on the preprint server bioRxiv reports that even though the fatality rate is significantly higher in diabetics, there is no evidence that this is due to direct viral infection of pancreatic beta cells, which produce the key hormone in glucose homeostasis, namely insulin.

1 Sep 2020

Mount Sinai hospitals win top quality achievement awards for stroke and cardiac care

Seven Mount Sinai Health System hospitals have received top quality achievement awards from the American Heart Association for ensuring that patients with stroke, heart failure, and severe heart attacks receive the most appropriate and safest treatment for the best possible outcomes.

1 Sep 2020

Educational mailing for atrial fibrillation patients fails to increase uptake of stroke prevention drugs

An educational mailing for atrial fibrillation patients and their clinicians did not increase uptake of stroke prevention drugs, according to results of the IMPACT-AFib trial presented in a Hot Line session today at ESC Congress 2020.

1 Sep 2020

Restrictive blood transfusion strategy has no negative impact on anemic heart attack patients

Restricting blood transfusion in anemic heart attack patients to those with very low hemoglobin levels saves blood with no negative impact on clinical outcomes.

1 Sep 2020

Common heart drugs are safe for patients hospitalized with COVID-19

Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020.

1 Sep 2020

Brain estrogen critical for astrocyte activation and neuroprotection

When the brain isn't getting enough oxygen, estrogen produced by neurons in both males and females hyperactivates another brain cell type called astrocytes to step up their usual support and protect brain function.

1 Sep 2020

Low dose colchicine significantly reduces risk of cardiovascular death

An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf, in collaboration with the Dutch Network for Cardiovascular Research (WCN) in the Netherlands, confirmed that low dose colchicine was safe, well-tolerated over the long-term, and significantly reduced the risk of cardiovascular death, heart attack, and ischemic stroke in patients with chronic coronary disease.

1 Sep 2020

Innovative training protocol leads to real physical and cognitive benefits

Researchers at the Smart-Aging Research Center (IDAC) at Tohoku University have developed an innovative training protocol that, utilizing immersive virtual reality (IVR), leads to real physical and cognitive benefits.

1 Sep 2020

Low dose colchicine significantly reduces risk of cardiovascular death

An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf,

1 Sep 2020

Diminished biological arousal before global pandemic may predict PTSD symptoms

People who did not have a large heart rate response to a stress task surprised researchers later -- after the onset of the COVID-19 pandemic -- when they showed more symptoms of post-traumatic stress disorder related to the crisis than others who also did the stress task and COVID-19 stress ratings.

1 Sep 2020

Problematic alcohol use linked to legal performance-enhancing substances

A new study published in the journal Pediatrics found that young adults aged 18-26 who used legal performance-enhancing substances were significantly more likely to report several problematic alcohol use and drinking-related risk behaviors seven years later.

1 Sep 2020

$Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction$

Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction

Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity compared to individualized background therapy in patients with heart failure with preserved ejection fraction

1 Sep 2020

Cardiology News and Research

Latest Cardiology News and Research

Treating critically ill COVID-19 patients with steroid improves chances of recovery

Rheumatoid arthritis drugs help improve the early stages of heart disease

New emergency program provides mental health care across Colorado

Circadian rhythms help in brain's unique process of waste removal

New theory changes the understanding of complex social interactions

Exponential rise in COVID-19 hospitalization risk with age due to waning T cell immunity

Simple test can help healthcare professionals identify patients at risk of type 2 diabetes

Misfiring brain cells may create swallowing difficulties in children with neurodevelopmental disorders

Negligible ACE2 expression in human beta-cells

Mount Sinai hospitals win top quality achievement awards for stroke and cardiac care

Educational mailing for atrial fibrillation patients fails to increase uptake of stroke prevention drugs

Restrictive blood transfusion strategy has no negative impact on anemic heart attack patients

Common heart drugs are safe for patients hospitalized with COVID-19

Brain estrogen critical for astrocyte activation and neuroprotection

Low dose colchicine significantly reduces risk of cardiovascular death

Innovative training protocol leads to real physical and cognitive benefits

Low dose colchicine significantly reduces risk of cardiovascular death

Diminished biological arousal before global pandemic may predict PTSD symptoms

Problematic alcohol use linked to legal performance-enhancing substances

Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cardiology News and Research

Latest Cardiology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in